INNOVATION PHARMACEUTICALS INC
0.22Up 0.0151 (7.369449 %)AS OF 3:59:10PM ET 10/02/2020 *****
Price Performance (Last 52 Weeks)
10/01/2020 +87.12%
Volume 6,245,126
Volume (10 day Average) 1,060,312
Volume (90 day Average) 2,947,199
Market Capitalization $71.14M
Shares Outstanding 347,186,000
===========================
Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.2049Down -0.0021 (-1.014493 %)AS OF 3:59:34PM ET 10/01/2020
Price Performance (Last 52 Weeks)
09/30/2020 +97.14%
Volume 663,935
Volume (10 day Average) 1,101,364
Volume (90 day Average) 3,052,130
Market Capitalization $71.87M
Shares Outstanding 347,186,000
===========================
Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.207Down -0.003 (-1.428571 %)AS OF 3:59:31PM ET 09/30/2020
Price Performance (Last 52 Weeks)
09/29/2020 +90.91%
Volume 475,784
Volume (10 day Average) 1,332,907
Volume (90 day Average) 3,079,547
Market Capitalization $72.91M
Shares Outstanding 347,186,000
===========================
Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.21Up 0.0035 (1.694915 %)AS OF 3:59:34PM ET 09/29/2020
Price Performance (Last 52 Weeks)
09/28/2020 +87.73%
Volume 1,046,776
Volume (10 day Average) 2,492,056
Volume (90 day Average) 3,115,573
Market Capitalization $71.69M
Shares Outstanding 347,186,000
===========================
Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.2065Up 0.0015 (0.731707 %)AS OF 3:58:07PM ET 09/28/2020
Price Performance (Last 52 Weeks)
09/25/2020 +86.36%
Volume 889,558
Volume (10 day Average) 2,492,056
Volume (90 day Average) 3,115,573
Market Capitalization $71.17M
Shares Outstanding 347,186,000
===========================
Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.205Down -0.0046 (-2.194656 %)AS OF 3:59:54PM ET 09/25/2020
Price Performance (Last 52 Weeks)
09/24/2020 +76.43%
Volume 1,986,343
Volume (10 day Average) 2,350,631
Volume (90 day Average) 3,165,002
Market Capitalization $72.77M
Shares Outstanding 347,186,000
===========================
Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.2096Down -0.00265 (-1.248528 %)AS OF 3:56:40PM ET 09/24/2020
Price Performance (Last 52 Weeks)
09/23/2020 +66.26%
Volume 1,119,577
Volume (10 day Average) 2,285,901
Volume (90 day Average) 3,164,069
Market Capitalization $73.69M
Shares Outstanding 347,186,000
===========================
Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.21225Down -0.00435 (-2.00831 %)AS OF 3:59:13PM ET 09/23/2020
Price Performance (Last 52 Weeks)
09/22/2020 +72.55%
Volume 1,396,982
Volume (10 day Average) 2,189,872
Volume (90 day Average) 3,163,592
Market Capitalization $75.20M
Shares Outstanding 347,186,000
===========================
Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.2166Down -0.0034 (-1.545455 %)AS OF 3:58:57PM ET 09/22/2020
Price Performance (Last 52 Weeks)
09/21/2020 +75.26%
Volume 1,215,571
Volume (10 day Average) 2,237,773
Volume (90 day Average) 3,173,287
Market Capitalization $76.38M
Shares Outstanding 347,186,000
===========================
Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.22Down -0.00775 (-3.402854 %)AS OF 3:56:48PM ET 09/21/2020
Price Performance (Last 52 Weeks)
09/18/2020 +71.89%
Volume 773,866
Volume (10 day Average) 2,322,367
Volume (90 day Average) 3,171,211
Market Capitalization $79.07M
Shares Outstanding 347,186,000
===========================
Historical Short Volume Data for IPIX
Date Close High Low Volume Sht Vol % of Vol Shtd
Oct 02 NA NA NA 6,245,126 3,662,097 58.64% *****
Oct 01 NA NA NA 663,935 247,471 37.27%
Sep 30 NA NA NA 475,784 313,022 65.79%
Sep 29 NA NA NA 1,046,776 482,802 46.12%
Sep 28 NA NA NA 889,558 424,164 47.68%
Sep 25 NA NA NA 1,986,343 760,038 38.26%
Sep 24 NA NA NA 1,119,577 253,095 22.61%
Sep 23 NA NA NA 1,396,982 710,712 50.87%
Sep 22 NA NA NA 1,215,571 595,465 48.99%
Sep 21 NA NA NA 773,866 299,446 38.69%
Sep 18 NA NA NA 1,031,043 447,658 43.42%
Sep 17 NA NA NA 1,078,135 663,697 61.56%
Sep 16 NA NA NA 2,788,722 1,268,722 45.49%
Sep 15 NA NA NA 12,948,414 5,507,122 42.53% ****
Sep 14 NA NA NA 568,409 299,316 52.66%
Sep 11 NA NA NA 572,086 344,622 60.24%
Sep 10 NA NA NA 472,282 269,628 57.09%
Sep 09 NA NA NA 436,695 320,996 73.51%
Sep 08 NA NA NA 1,694,578 1,010,478 59.63% ***
Sep 04 NA NA NA 1,619,804 1,072,314 66.20%
Sep 03 NA NA NA 1,467,420 940,998 64.13%
Sep 02 NA NA NA 1,256,071 716,978 57.08%
Sep 01 NA NA NA 933,410 471,778 50.54%
Aug 31 NA NA NA 1,032,019 570,486 55.28%
Aug 28 NA NA NA 913,239 455,111 49.83%
Aug 27 NA NA NA 913,446 574,129 62.85%
Aug 26 NA NA NA 1,601,531 1,059,780 66.17% **
Aug 25 NA NA NA 1,398,358 759,317 54.30%
Aug 24 NA NA NA 6,015,802 3,187,537 52.99% *
Aug 21 NA NA NA 1,312,168 661,297 50.40%
Aug 20 NA NA NA 1,111,127 621,873 55.97%
Aug 19 NA NA NA 1,201,893 581,350 48.37%
Aug 18 NA NA NA 1,397,414 882,970 63.19%
Aug 17 NA NA NA 1,128,186 568,549 50.39%
Aug 14 NA NA NA 1,423,346 692,153 48.63%
Aug 13 NA NA NA 1,057,579 548,523 51.87%
Aug 12 NA NA NA 1,406,491 681,043 48.42%
Aug 11 NA NA NA 1,659,920 850,348 51.23%
Aug 10 NA NA NA 2,015,792 793,871 39.38%
Aug 07 NA NA NA 1,686,981 795,055 47.13%
Aug 06 NA NA NA 2,479,779 1,198,690 48.34%
Aug 05 NA NA NA 1,092,323 504,530 46.19%
Aug 04 NA NA NA 2,625,758 1,630,279 62.09%
Aug 03 NA NA NA 3,611,854 2,507,917 69.44%
Jul 31 NA NA NA 1,035,908 527,927 50.96%
Jul 30 NA NA NA 4,421,368 2,765,370 62.55%
Jul 29 NA NA NA 1,584,578 865,553 54.62%
Jul 28 NA NA NA 1,478,641 947,848 64.10%
Jul 27 NA NA NA 5,429,584 2,982,599 54.93%
Jul 24 NA NA NA 2,804,276 1,635,949 58.34%
Jul 23 NA NA NA 1,443,141 852,554 59.08%
Jul 22 NA NA NA 1,583,764 877,353 55.40%
Jul 21 NA NA NA 2,471,827 1,406,938 56.92%
Jul 20 NA NA NA 7,011,994 3,903,198 55.66%
Jul 17 NA NA NA 1,700,006 948,578 55.80%
Jul 16 NA NA NA 1,572,843 950,607 60.44%
Jul 15 NA NA NA 3,122,082 1,883,905 60.34%
Jul 14 NA NA NA 6,521,081 2,175,892 33.37%
Jul 13 NA NA NA 8,151,877 4,078,491 50.03%
Jul 10 NA NA NA 2,154,827 932,019 43.25%
Jul 09 NA NA NA 1,892,612 1,107,610 58.52%
Jul 08 NA NA NA 2,573,759 1,462,374 56.82%
Jul 07 NA NA NA 4,061,212 2,594,248 63.88%
Jul 06 NA NA NA 2,287,553 1,226,968 53.64%
Jul 02 NA NA NA 3,788,429 1,822,707 48.11%
Jul 01 NA NA NA 1,521,940 646,991 42.51%
Jun 30 NA NA NA 1,742,511 982,243 56.37%
Jun 29 NA NA NA 2,815,051 1,614,501 57.35%
Jun 26 NA NA NA 3,288,168 1,755,618 53.39%
Jun 25 NA NA NA 2,908,354 1,679,709 57.75%
Jun 24 NA NA NA 7,625,067 4,299,436 56.39%
Jun 23 NA NA NA 12,750,039 6,169,402 48.39%
Jun 22 NA NA NA 7,884,928 3,996,456 50.68%
Jun 19 NA NA NA 15,326,213 9,254,306 60.38%
*****Innovation Pharmaceuticals Announces Pre-IND Meeting Request Granted by FDA for the Study of Brilacidin for the Treatment of COVID-19
GLOBENEWSWIRE – 10:00 AM ET 10/02/2020
****Laboratory Testing of Brilacidin for COVID-19 in Combination with Remdesivir Reduces Viral Load by Nearly 100 Percent
GLOBENEWSWIRE – 9:00 AM ET 09/15/2020
***Innovation Pharmaceuticals Announces Publication of Independent Research on Kevetrin, the Company’s p53 Drug Candidate, in Oncology Reports
GLOBENEWSWIRE – 10:00 AM ET 09/08/2020
**Dr. William F. DeGrado, a Discoverer of Brilacidin, Joins Innovation Pharmaceuticals as Scientific Advisor
GLOBENEWSWIRE – 9:30 AM ET 08/26/2020
*COVID-19 Drug Candidate Brilacidin Achieves a Selectivity Index Among the Highest Reported, Exhibiting Potent Anti-SARS-CoV-2 Activity at Low Concentrations; Clinical Trial Forthcoming
GLOBENEWSWIRE – 8:00 AM ET 08/24/2020
Innovation Pharmaceuticals and U.S. Regional Biocontainment Laboratory Nearing Completion of Brilacidin Anti-SARS-CoV-2 (COVID-19) In Vitro Testing
GLOBENEWSWIRE – 8:00 AM ET 08/04/2020
Innovation Pharmaceuticals Grants Licensing Rights to Fox Chase Chemical Diversity Center, Inc. for Antifungal Technology
GLOBENEWSWIRE – 8:00 AM ET 07/22/2020
Innovation Pharmaceuticals’ Brilacidin Inhibits Novel Coronavirus (COVID-19) by Almost 90% at the Lowest Concentration Tested to Date in a Human Lung Cell Line
GLOBENEWSWIRE – 7:30 AM ET 07/20/2020
Innovation Pharmaceuticals – Clinical Trial Testing of Brilacidin Against SARS-CoV-2 (COVID-19) Targeted to Commence Q4 2020
GLOBENEWSWIRE – 8:00 AM ET 07/13/2020
In Vitro Testing of Innovation Pharmaceuticals’ Brilacidin for COVID-19 Shows Consistent Anti-SARS-CoV-2 Efficacy; Manufacturing Preparation Underway for COVID-19 Clinical Trial
GLOBENEWSWIRE – 8:00 AM ET 07/07/2020
Innovation Pharmaceuticals’ Brilacidin Inhibits SARS-CoV-2 (COVID-19) by 97 Percent in a Human Lung Cell Line
GLOBENEWSWIRE – 7:30 AM ET 06/17/2020
IPIX *volume* by month as *reported* to Finra 2020
IPIX YTD *Volume* as of EO AUG 2020 ~ 488,442,699
AUG 2020 ~ 37,279,662
JUL 2020 ~ 68,767,947
JUN 2020 ~ 116,020,124
MAY 2020 ~ 51,886,542
APR 2020 ~ 78,324,274
MAR 2020 ~ 86,903,508
FEB 2020 ~ 35,015,032
JAN 2020 ~ 14,245,610
https://otce.finra.org/otce/marketStatistics/...hareVolume
NR is between a rock and a hard space re: IPIX (stock)
https://investorshangout.com/post/view?id=5703011
as always best to all Innovation Pharma investors ..
4kids
(10)
(0)
